ConductScience.org, home

Paper3182103

Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer.

Zurawski VR and 3 others. Int J Cancer, 1988. Cited by 205 papers, by iCite.

Cite this record

ConductScience Library. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Papers, record 3182103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3182103

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer.
PubMed
Journal
Int J Cancer
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
205
iCite
Relative citation ratio, by iCite
6.11
iCite
Revised in PubMed
2021-01-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zurawski VR JrV R
2Orjaseter HH
3Andersen AA
4Jellum EE

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, Tumor-Associated, CarbohydrateMajor topic
Ovarian NeoplasmsMajor topic
Adult
Blood Banks
Female
Humans
Middle Aged
Retrospective Studies

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
1 R43 CA 40945-01NCI NIH HHSUnited StatesR43CA409450PubMedNIH RePORTER
1 R44 CA 40945-02NCI NIH HHSUnited StatesR44CA409450PubMedNIH RePORTER
R43CA040945NIHNIH RePORTER
R44CA040945NIHNIH RePORTER

Download CSV of grants

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.

PMIDTitleJournalYearIn PapersSource
40783897High-density lectin microarray uncovers stage-specific plasma glycoprofiling signatures for non-muscle-invasive and muscle-invasive bladder cancer.Int Urol Nephrol2026https://conductscience.org/library/papers/40783897PubMed
40071681Tumor Glycosylation: A Main Player in the Modulation of Immune Responses.Eur J Immunol2025https://conductscience.org/library/papers/40071681PubMed
39587891Diagnostic value and application prospect of tumor abnormal protein test in head and neck tumors.Sci Prog2024https://conductscience.org/library/papers/39587891PubMed
39098853Glycosylation: mechanisms, biological functions and clinical implications.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39098853PubMed
38910518Recent advances in N-glycan biomarker discovery among human diseases.Acta Biochim Biophys Sin (Shanghai)2024https://conductscience.org/library/papers/38910518PubMed
38861100Glycosylation editing: an innovative therapeutic opportunity in precision oncology.Mol Cell Biochem2025https://conductscience.org/library/papers/38861100PubMed
38384845The transcriptional landscape of glycosylation-related genes in cancer.iScience2024https://conductscience.org/library/papers/38384845PubMed
37958700Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/37958700PubMed
37455827Capitalizing glycomic changes for improved biomarker-based cancer diagnostics.Explor Target Antitumor Ther2023https://conductscience.org/library/papers/37455827PubMed
37082219New trends in diagnosing and treating ovarian cancer using nanotechnology.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/37082219PubMed
36338982Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer.Front Genet2022https://conductscience.org/library/papers/36338982PubMed
36037117Ovarian Cancer-Self Assessment: An Innovation for Early Detection and Risk Assessment of Ovarian Cancer.Asian Pac J Cancer Prev2022https://conductscience.org/library/papers/36037117PubMed
35797639High-Throughput Glycomic Methods.Chem Rev2022https://conductscience.org/library/papers/35797639PubMed
35740550Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.Cancers (Basel)2022https://conductscience.org/library/papers/35740550PubMed
35159077
Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian Tumour Analysis (IOTA) Simple Rules.
Cancers (Basel)2022https://conductscience.org/library/papers/35159077PubMed
34495529Mucin-Type O-GalNAc Glycosylation in Health and Disease.Adv Exp Med Biol2021https://conductscience.org/library/papers/34495529PubMed
34093804Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.J Cancer2021https://conductscience.org/library/papers/34093804PubMed
33302373Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.Int J Mol Sci2020https://conductscience.org/library/papers/33302373PubMed
31717613Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging.Diagnostics (Basel)2019https://conductscience.org/library/papers/31717613PubMed
31428516High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids.Oncoimmunology2019https://conductscience.org/library/papers/31428516PubMed

See all 51 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3182103

GET https://conductscience.org/api/papers/v1/3182103/cited_by?page=2